Citigroup Inc Infla Rx N.V. Transaction History
Citigroup Inc
- $217 Billion
- Q3 2025
A detailed history of Citigroup Inc transactions in Infla Rx N.V. stock. As of the latest transaction made, Citigroup Inc holds 1,301 shares of IFRX stock, worth $1,730. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,301
Previous 1,301
-0.0%
Holding current value
$1,730
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding IFRX
# of Institutions
31Shares Held
19.2MCall Options Held
52KPut Options Held
0-
Suvretta Capital Management, LLC New York, NY6.48MShares$8.62 Million0.25% of portfolio
-
Bank Of America Corp Charlotte, NC2.48MShares$3.29 Million0.0% of portfolio
-
683 Capital Management, LLC New York, NY2.25MShares$2.99 Million0.17% of portfolio
-
Ra Capital Management, L.P. Boston, MA1.97MShares$2.62 Million0.04% of portfolio
-
Eversept Partners, LP New York, NY1.73MShares$2.3 Million0.18% of portfolio
About InflaRx N.V.
- Ticker IFRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 44,203,800
- Market Cap $58.8M
- Description
- InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...